New drugs

EPCLUSA is a new drug that cures Hepatitis C. Gilead has priced a 12-week regimen of Epclusa to cost $74,760. There are 3 million people in the United States with Hep C with 17,000 new cases each year. The cost would be over $200 billion but the cost would come down as more people are treated. What happens if other cures are developed. For example, 30 million Americans have diabetes and at a similar cost this would be $2.5 trillion. It quickly becomes obvious that rationing will be necessary as the drug companies keep coming up with new cures. Of course wealthy people will buy the drug no matter the cost. With the emphasis on fairness will laws be proposed to prohibit the wealthy from buying these drugs.